Transforming Growth Factor-β1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering either Activation or Secretion of the Mutant Protein
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (9) , 7718-7724
- https://doi.org/10.1074/jbc.m208857200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like CellsBiochemical and Biophysical Research Communications, 1998
- The L45 loop in type I receptors for TGF‐β family members is a critical determinant in specifying Smad isoform activationPublished by Wiley ,1998
- The COOH-terminal ends of internal signal and signal-anchor sequences are positioned differently in the ER translocase.The Journal of cell biology, 1994
- Mechanism of activation of the TGF-β receptorNature, 1994
- In vivo induction of bone by recombinant human transforming growth factor β1Journal of Bone and Mineral Research, 1991
- Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1.The Journal of cell biology, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Transformation by v- sis Occurs by an Internal Autoactivation MechanismScience, 1989
- Activation of the bone-derived latent TGF beta complex by isolated osteoclastsBiochemical and Biophysical Research Communications, 1989
- Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature.Journal of Medical Genetics, 1972